Updates on Current Role and Practice of Lung Ablation

Area of Science:

• Interventional oncology
• Thoracic oncology
• Minimally invasive cancer treatment

Background:

• Ablative techniques are increasingly recognized for managing thoracic malignancies.
• Lung cancer remains a primary and challenging indication for lung ablation.
• Expanding indications and improving efficacy of ablative therapies are noted.

Purpose of the Study:

• To review the role of ablation in thoracic neoplasm management.
• To discuss post-ablation imaging features and follow-up protocols.
• To highlight the importance of radiologist familiarity with ablation outcomes.

Main Methods:

• Review of current literature on ablative techniques for thoracic malignancies.
• Analysis of survival data comparing ablation with resection and radiation.
• Discussion of indications, including lung cancer, mesothelioma, and thymoma metastases.

Main Results:

• Equivalent survival rates between ablation, sublobar resection, and stereotactic body radiation for inoperable lung cancer.
• Lung ablation shows promise for oligometastatic disease, recurrent mesothelioma, and pleural metastases with good local control.
• Ablation offers benefits like limited downtime, repeatability, and preserved respiratory function.

Conclusions:

• Lung ablation is a viable therapeutic option for thoracic malignancies, particularly in select patient groups.
• Standardized imaging follow-up is crucial for detecting complications and recurrence after ablation.
• Thoracic radiologists play a key role in identifying suitable candidates and interpreting post-ablation imaging.